Chengshui Chen

2.2k total citations
92 papers, 1.5k citations indexed

About

Chengshui Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chengshui Chen has authored 92 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 34 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Chengshui Chen's work include Neonatal Respiratory Health Research (16 papers), Fibroblast Growth Factor Research (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Chengshui Chen is often cited by papers focused on Neonatal Respiratory Health Research (16 papers), Fibroblast Growth Factor Research (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Chengshui Chen collaborates with scholars based in China, Germany and United States. Chengshui Chen's co-authors include Xiangdong Wang, Lin Shi, Nian Dong, Xiangdong Wang, Yuping Li, Savério Bellusci, Yiran Hu, Linjing Liu, Jiahao Zeng and Qiang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Clinical Infectious Diseases.

In The Last Decade

Chengshui Chen

84 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengshui Chen China 22 734 404 192 177 168 92 1.5k
Anand Srivastava United States 24 852 1.2× 345 0.9× 155 0.8× 381 2.2× 150 0.9× 94 2.5k
Katsuya Ikuta Japan 24 680 0.9× 188 0.5× 194 1.0× 147 0.8× 218 1.3× 103 2.2k
Rebecca E. Oberley‐Deegan United States 23 619 0.8× 420 1.0× 148 0.8× 175 1.0× 173 1.0× 72 1.8k
Cheng Fan China 21 921 1.3× 436 1.1× 457 2.4× 245 1.4× 274 1.6× 175 2.0k
Xiaolin Fan United States 16 246 0.3× 292 0.7× 159 0.8× 114 0.6× 252 1.5× 46 1.5k
Fei Xiao China 24 898 1.2× 338 0.8× 493 2.6× 92 0.5× 189 1.1× 126 1.7k
Wenyang Jiang China 22 1.0k 1.4× 480 1.2× 550 2.9× 193 1.1× 294 1.8× 50 2.0k
Liang Guo China 23 543 0.7× 160 0.4× 271 1.4× 198 1.1× 197 1.2× 116 1.8k
Graça Porto Portugal 32 565 0.8× 239 0.6× 207 1.1× 93 0.5× 118 0.7× 103 3.2k

Countries citing papers authored by Chengshui Chen

Since Specialization
Citations

This map shows the geographic impact of Chengshui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengshui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengshui Chen more than expected).

Fields of papers citing papers by Chengshui Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengshui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengshui Chen. The network helps show where Chengshui Chen may publish in the future.

Co-authorship network of co-authors of Chengshui Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chengshui Chen. A scholar is included among the top collaborators of Chengshui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengshui Chen. Chengshui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Yanxia, Bingxi He, Haibo Xu, et al.. (2025). Evidence that metformin promotes fibrosis resolution via activating alveolar epithelial stem cells and FGFR2b signaling. Acta Pharmaceutica Sinica B. 15(9). 4711–4729.
3.
4.
Lin, Yu-Ting, Meiyu Quan, Xibin Wang, et al.. (2024). Parkin deficiency exacerbates particulate matter-induced injury by enhancing airway epithelial necroptosis. The Science of The Total Environment. 953. 175922–175922. 3 indexed citations
5.
Jiang, Xinqing, Sijia Chen, Hua Zhou, et al.. (2024). MiR-1307-5p enhances fibroblast transdifferentiation to exacerbate chronic obstructive pulmonary disease through regulating FBXL16/HIF1α axis. Respiratory Research. 25(1). 376–376.
6.
7.
8.
9.
Wang, Jie, Feng Zhang, Weiwei Yang, et al.. (2023). FGF1 ameliorates obesity‐associated hepatic steatosis by reversing IGFBP2 hypermethylation. The FASEB Journal. 37(4). e22881–e22881. 8 indexed citations
10.
Zhong, Shan, Chengshui Chen, Yang Li, et al.. (2023). Identification of circRNA-associated ceRNA networks in peripheral blood mononuclear cells as potential biomarkers for chronic obstructive pulmonary disease. Bioscience Reports. 43(10). 1 indexed citations
11.
Zhang, Qimeng, Bingbing Zhu, Rong Chen, et al.. (2023). Acetalized starch-based nanoparticles stabilized acid-sensitive Pickering emulsion as a potential antitumor drug carrier. International Journal of Biological Macromolecules. 244. 125393–125393. 20 indexed citations
12.
Liu, Li, Kankai Wang, Qian Yao, et al.. (2022). Fibroblast growth factor 10 protects against particulate matter-induced lung injury by inhibiting oxidative stress-mediated pyroptosis via the PI3K/Akt/Nrf2 signaling pathway. International Immunopharmacology. 113(Pt A). 109398–109398. 17 indexed citations
13.
Wang, Qiang, Li Liu, Junjie Chen, et al.. (2022). FGF10 protects against particulate matter (PM)-induced lung injury via regulation of endoplasmic reticulum stress. International Immunopharmacology. 105. 108552–108552. 6 indexed citations
14.
Pan, Shuang, et al.. (2022). Hyperlipemia pancreatitis onset time affects the association between elevated serum triglyceride levels and disease severity. Lipids in Health and Disease. 21(1). 49–49. 8 indexed citations
15.
Jin, Shengwei, Hui Jeong An, Tong Zhou, et al.. (2021). Sex- and age-specific clinical and immunological features of coronavirus disease 2019. PLoS Pathogens. 17(3). e1009420–e1009420. 19 indexed citations
16.
Vesali, Samira, Roya Hosseini, Mehdi Totonchi, et al.. (2021). Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection. Frontiers in Cell and Developmental Biology. 9. 676150–676150. 9 indexed citations
17.
Chen, Chengshui, et al.. (2020). Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis. Frontiers in Bioengineering and Biotechnology. 8. 569865–569865. 11 indexed citations
18.
Dong, Nian, Lin Shi, Diane C. Wang, Chengshui Chen, & Xiangdong Wang. (2016). Role of epigenetics in lung cancer heterogeneity and clinical implication. Seminars in Cell and Developmental Biology. 64. 18–25. 41 indexed citations
19.
Li, Yuping, et al.. (2015). Inhibition of FHL1 inhibits cigarette smoke extract-induced proliferation in pulmonary arterial smooth muscle cells. Molecular Medicine Reports. 12(3). 3801–3808. 11 indexed citations
20.
Yan, Fugui, Chengshui Chen, Jiyong Jing, et al.. (2010). Association between polymorphism of glutathione S-transferase P1 and chronic obstructive pulmonary disease: A meta-analysis. Respiratory Medicine. 104(4). 473–480. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anand Srivastava Breakdown of academic impact, for papers by Katsuya Ikuta Breakdown of academic impact, for papers by Rebecca E. Oberley‐Deegan Breakdown of academic impact, for papers by Cheng Fan Breakdown of academic impact, for papers by Xiaolin Fan Breakdown of academic impact, for papers by Fei Xiao Breakdown of academic impact, for papers by Wenyang Jiang Breakdown of academic impact, for papers by Liang Guo Breakdown of academic impact, for papers by Graça Porto
Rankless by CCL
2026